摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E) 2-styryl-6-carboxymethyl-1,1'-biphenyl-3'-carboxylic acid | 163117-98-4

中文名称
——
中文别名
——
英文名称
(E) 2-styryl-6-carboxymethyl-1,1'-biphenyl-3'-carboxylic acid
英文别名
2-styryl-6-carboxymethyl-1,1'-biphenyl-3'-carboxylic acid;3-[2-(carboxymethyl)-6-[(E)-2-phenylethenyl]phenyl]benzoic acid
(E) 2-styryl-6-carboxymethyl-1,1'-biphenyl-3'-carboxylic acid化学式
CAS
163117-98-4
化学式
C23H18O4
mdl
——
分子量
358.394
InChiKey
KGKBKNVVOPOLMA-OUKQBFOZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5
  • 重原子数:
    27
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.04
  • 拓扑面积:
    74.6
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    stannane 、 3'-Carboethoxy-(E)-2-[(5,6,7,8-tetrahydro-5,5,8,8,-tetramethyl-2-naphthalenyl)-1-propenyl]-[1,1'-biphenyl]-6-acetic acid, ethyl ester 、 (E) 2-styryl-6-carboxymethyl-1,1'-biphenyl-3'-carboxylic acid 、 3'-carboethoxy-2-trifluoromethylsulphonyloxy-1,1'-biphenyl-6-acetic acid, ethyl ester 以 正己烷乙酸乙酯 为溶剂, 生成 3'-carboxy-(E)-2-[(5,6,7,8-tetrahydro-5,5,8,8,-tetramethyl-2-naphthalenyl)-1-propenyl]-[1,1'-biphenyl]-6-acetic acid
    参考文献:
    名称:
    Biaryl phospholipase A.sub.2 inhibitors
    摘要:
    某些新型联苯化合物是有效的磷脂酶A.sub.2(PLA.sub.2)抑制剂。
    公开号:
    US05391817A1
  • 作为产物:
    描述:
    3'-carboethoxy-2-trifluoromethylsulphonyloxy-1,1'-biphenyl-6-acetic acid, ethyl ester 在 bis-triphenylphosphine-palladium(II) chloride 、 sodium hydroxidelithium chloride 作用下, 以 四氢呋喃甲醇N,N-二甲基甲酰胺 为溶剂, 反应 2.33h, 生成 (E) 2-styryl-6-carboxymethyl-1,1'-biphenyl-3'-carboxylic acid
    参考文献:
    名称:
    Biaryl diacid inhibitors of human s-PLA 2 with anti-inflammatory activity
    摘要:
    Twenty-four hydrophobic dicarboxylic acids are described which were evaluated as inhibitors of 14 kDa human platelet phospholipase A(2) (HP-PLA(2)). In general, biarylacetic acid derivatives were found to be more active than biaryl acids or biaryl-propanoic acids. More potent inhibitors were obtained when hydrophobic groups were attached to the biaryl acid nucleus using an olefin linkage as compared to an ether linkage. Compounds with larger hydrophobic groups were usually more potent inhibitors of HP-PLA(2). Five of the compounds disclosed in this report (2, 4, 28, 36b and 36i) were found to possess significant anti-inflammatory activity in a phorbol ester induced mouse ear edema model of chronic inflammation. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(00)00047-x
点击查看最新优质反应信息

文献信息

  • Biaryl phospholipase A2 inhibitors
    申请人:BRISTOL-MYERS SQUIBB COMPANY
    公开号:EP0664282A1
    公开(公告)日:1995-07-26
    Biaryl compounds, effective phospholipase A₂ (PLA₂) inhibitors of Formulas I and II: wherein: Y= COOH, CH₂CO₂H, H, F, Cl, Br, I, COOR', CH₂CO₂R', CONH₂, COR'', CHO, CH₂OH, CH₂OR'', OH, OR'', CF₃, C₁₋₆ alkyl, C₁₋₆ alkenyl, C₁₋₆ haloalkyl, NO₂, P(O) (OH)₂, SO₂H, or SO₃H; Z= H, F, Cl, Br, I, CONH₂, COR'', CHO, CH₂OH, CH₂OR'', OH, OR'', CF₃, C₁₋₆ alkyl, C₁₋₆ alkenyl, C₁₋₆ haloalkyl, NO₂, P(O)(OH)₂, SO₂H, or SO₃H; X= (CH₂)n, n = 0, 1, or 2; or a cis or trans CH=CH; R= substituted or unsubstituted alkyl, aryl, arylalkyl, alkyloxy, arylalkyloxy, alkenyl, or arylalkenyl groups with the proviso that R must have 8 or more carbons; R'= H, C₁₋₆ alkyl, C(R¹)₂OC(O)R², CH₂CH₂NR³R⁴, CH₂CH₂CH₂NR³R⁴, or other groups yielding physiologically hydrolyzable esters; R''= C₁₋₆ alkyl; R¹= H, CH₃, C₂H₅, CH₂CH₂CH₃; R₂= C₆₋₁₂ aryl, C₁₋₇ linear, branched or cyclic alkyl, or C₁₋₇ linear branched or cyclic alkoxy; R³= R⁴, or, it may be linked with R⁴, to form a C₃-C₆ cycloalkyl or a -CH₂CH₂OCH₂CH₂- group; and R⁴= C₁₋₃ alkyl; or salts thereof.
    式 I 和 II 的有效磷脂酶 A₂(PLA₂)抑制剂--联苯化合物: 其中 Y= COOH、CH₂CO₂H、H、F、Cl、Br、I、COOR'、CH₂CO₂R'、CONH₂、COR''、CHO、CH₂OH、CH₂OR''、OH、OR''、CF₃、C₁₋₆ 烷基、C₁₋₆ 烯基、C₁₋₆ 卤代烷基、NO₂、P(O) (OH)₂、SO₂H 或 SO₃H; Z= H、F、Cl、Br、I、CONH₂、COR''、CHO、CH₂OH、CH₂OR''、OH、OR''、CF₃、C₁₋₆ 烷基、C₁₋₆ 烯基、C₁₋₆ 卤代烷基、NO₂、P(O)(OH)₂、SO₂H 或 SO₃H; X= (CH₂)n,n = 0、1 或 2;或顺式或反式 CH=CH; R= 取代或未取代的烷基、芳基、芳烷基、烷氧基、芳烷氧基、烯基或芳烯基,但 R 必须具有 8 个或 8 个以上碳原子; R'=H、C₁₋₆烷基、C(R¹)₂OC(O)R²、CH₂CH₂NR³R⁴、CH₂CH₂CH₂NR³R⁴或其他可产生生理性水解酯的基团; R''= C₁₋₆ 烷基; R¹= h、ch₃、c₂h₅、ch₂ch₂ch₃; R₂= C₆₋₁₂ 芳基,C₁₋₇ 直链、支链或环状烷基,或 C₁₋₇ 直链、支链或环状烷氧基; R³= R⁴,或可与 R⁴ 连接,形成 C₃-C₆ 环烷基或 -CH₂CH₂OCH₂CH₂- 基团;以及 R⁴= C₁₋₃ 烷基;或其盐。
  • US5391817A
    申请人:——
    公开号:US5391817A
    公开(公告)日:1995-02-21
  • Biaryl phospholipase A.sub.2 inhibitors
    申请人:Bristol-Myers Squibb
    公开号:US05391817A1
    公开(公告)日:1995-02-21
    Certain novel biaryl compounds are effective phospholipase A.sub.2 (PLA.sub.2) inhibitors.
    某些新型联苯化合物是有效的磷脂酶A.sub.2(PLA.sub.2)抑制剂。
  • Biaryl diacid inhibitors of human s-PLA 2 with anti-inflammatory activity
    作者:Dane M. Springer、Bing-Yu Luh、Joanne J. Bronson、Katharine E. McElhone、Muzammil M. Mansuri、Kurt R. Gregor、David O. Nettleton、Paul L. Stanley、Kenneth M. Tramposch
    DOI:10.1016/s0968-0896(00)00047-x
    日期:2000.5
    Twenty-four hydrophobic dicarboxylic acids are described which were evaluated as inhibitors of 14 kDa human platelet phospholipase A(2) (HP-PLA(2)). In general, biarylacetic acid derivatives were found to be more active than biaryl acids or biaryl-propanoic acids. More potent inhibitors were obtained when hydrophobic groups were attached to the biaryl acid nucleus using an olefin linkage as compared to an ether linkage. Compounds with larger hydrophobic groups were usually more potent inhibitors of HP-PLA(2). Five of the compounds disclosed in this report (2, 4, 28, 36b and 36i) were found to possess significant anti-inflammatory activity in a phorbol ester induced mouse ear edema model of chronic inflammation. (C) 2000 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

(E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E/Z)-他莫昔芬-d5 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 鼓槌石斛素 高黄绿酸 顺式白藜芦醇三甲醚 顺式白藜芦醇 顺式己烯雌酚 顺式-桑皮苷A 顺式-曲札芪苷 顺式-二苯乙烯 顺式-beta-羟基他莫昔芬 顺式-a-羟基他莫昔芬 顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯 顺式-1,2-二苯基环丁烷 顺-均二苯乙烯硼酸二乙醇胺酯 顺-4-硝基二苯乙烯 顺-1-异丙基-2,3-二苯基氮丙啶 阿非昔芬 阿里可拉唑 阿那曲唑二聚体 阿托伐他汀环氧四氢呋喃 阿托伐他汀环氧乙烷杂质 阿托伐他汀环(氟苯基)钠盐杂质 阿托伐他汀环(氟苯基)烯丙基酯 阿托伐他汀杂质D 阿托伐他汀杂质94 阿托伐他汀内酰胺钠盐杂质 阿托伐他汀中间体M4 阿奈库碘铵 银松素 铒(III) 离子载体 I 钾钠2,2'-[(E)-1,2-乙烯二基]二[5-({4-苯胺基-6-[(2-羟基乙基)氨基]-1,3,5-三嗪-2-基}氨基)苯磺酸酯](1:1:1) 钠{4-[氧代(苯基)乙酰基]苯基}甲烷磺酸酯 钠;[2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙基]苯基]硫酸盐 钠4-氨基二苯乙烯-2-磺酸酯 钠3-(4-甲氧基苯基)-2-苯基丙烯酸酯 重氮基乙酸胆酯酯 醋酸(R)-(+)-2-羟基-1,2,2-三苯乙酯 酸性绿16 邻氯苯基苄基酮 那碎因盐酸盐 那碎因[鹼] 达格列净杂质54 辛那马维林 赤藓型-1,2-联苯-2-(丙胺)乙醇 赤松素 败脂酸,丁基丙-2-烯酸酯,甲基2-甲基丙-2-烯酸酯,2-甲基丙-2-烯酸